| http://dbpedia.org/ontology/abstract
|
Cubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash ($8.4 billion).
|
| http://dbpedia.org/ontology/foundingYear
|
1992
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Pharmaceuticals +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Lexington%2C_Massachusetts +
|
| http://dbpedia.org/ontology/parentCompany
|
http://dbpedia.org/resource/Merck_&_Co. +
|
| http://dbpedia.org/ontology/product
|
http://www.cubist.com/products/ +
|
| http://dbpedia.org/ontology/revenue
|
9.264E8
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Cubist_Pharmaceuticals_Logo.svg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.cubist.com/products/ +
, http://www.cubist.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
31836335
|
| http://dbpedia.org/ontology/wikiPageLength
|
7538
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1122471321
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Methicillin-resistant_Staphylococcus_aureus +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/Category:2015_mergers_and_acquisitions +
, http://dbpedia.org/resource/Category:Defunct_pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Tedizolid +
, http://dbpedia.org/resource/Constipation +
, http://dbpedia.org/resource/Daptomycin +
, http://dbpedia.org/resource/Category:Merck_&_Co. +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_disestablished_in_2015 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1992 +
, http://dbpedia.org/resource/Category:Companies_based_in_Lexington%2C_Massachusetts +
, http://dbpedia.org/resource/Category:1992_establishments_in_Massachusetts +
, http://dbpedia.org/resource/Lexington%2C_Massachusetts +
, http://dbpedia.org/resource/Michael_Bonney +
, http://dbpedia.org/resource/Lipopeptides +
, http://dbpedia.org/resource/Category:2015_disestablishments_in_Massachusetts +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Merck_&_Co. +
, http://dbpedia.org/resource/United_States_dollar +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1992 +
, http://dbpedia.org/resource/Pharmaceuticals +
, http://dbpedia.org/resource/Category:Biotechnology_companies_disestablished_in_2015 +
, http://dbpedia.org/resource/Biopharmaceutical +
, http://dbpedia.org/resource/Teva_Pharmaceutical_Industries +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/Category:American_companies_established_in_1992 +
, http://dbpedia.org/resource/Category:Defunct_companies_based_in_Massachusetts +
, http://dbpedia.org/resource/Optimer_Pharmaceuticals +
, http://dbpedia.org/resource/Paul_Schimmel +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_Massachusetts +
, http://dbpedia.org/resource/Trius_Therapeutics +
, http://dbpedia.org/resource/Public +
|
| http://dbpedia.org/property/defunct
|
2015
|
| http://dbpedia.org/property/foundation
|
1992
|
| http://dbpedia.org/property/homepage
|
http://www.cubist.com/ +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Pharmaceuticals +
|
| http://dbpedia.org/property/keyPeople
|
Robert J. Perez, President, CEO;
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Lexington%2C_Massachusetts +
|
| http://dbpedia.org/property/logo
|
Cubist Pharmaceuticals Logo.svg
|
| http://dbpedia.org/property/logoSize
|
228
|
| http://dbpedia.org/property/name
|
Cubist Pharmaceuticals, INC
|
| http://dbpedia.org/property/parent
|
http://dbpedia.org/resource/Merck_&_Co. +
|
| http://dbpedia.org/property/products
|
http://www.cubist.com/products/ +
|
| http://dbpedia.org/property/revenue
|
$926.4 million USD
|
| http://dbpedia.org/property/tradedAs
|
NASDAQ:CBST
|
| http://dbpedia.org/property/type
|
Subsidiary
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Coord +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Merck_&_Co. +
, http://dbpedia.org/resource/Template:Profit +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Pharmaceutical_companies_of_the_United_States +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_disestablished_in_2015 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_Massachusetts +
, http://dbpedia.org/resource/Category:Companies_based_in_Lexington%2C_Massachusetts +
, http://dbpedia.org/resource/Category:American_companies_established_in_1992 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_disestablished_in_2015 +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:Defunct_pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:2015_disestablishments_in_Massachusetts +
, http://dbpedia.org/resource/Category:1992_establishments_in_Massachusetts +
, http://dbpedia.org/resource/Category:Defunct_companies_based_in_Massachusetts +
, http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1992 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1992 +
, http://dbpedia.org/resource/Category:Merck_&_Co. +
, http://dbpedia.org/resource/Category:2015_mergers_and_acquisitions +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/S +
|
| http://www.georss.org/georss/point
|
42.42366666666667 -71.24247222222222
|
| http://www.w3.org/2003/01/geo/wgs84 pos#geometry
|
POINT(-71.242469787598 42.423667907715)
|
| http://www.w3.org/2003/01/geo/wgs84 pos#lat
|
42.423667907715
|
| http://www.w3.org/2003/01/geo/wgs84 pos#long
|
-71.242469787598
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.417686.a +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Cubist_Pharmaceuticals?oldid=1122471321&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Cubist_Pharmaceuticals_Logo.svg +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.cubist.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Cubist_Pharmaceuticals +
|
| http://xmlns.com/foaf/0.1/name
|
Cubist Pharmaceuticals, INC
|
| owl:sameAs |
http://yago-knowledge.org/resource/Cubist_Pharmaceuticals +
, http://dbpedia.org/resource/Cubist_Pharmaceuticals +
, http://rdf.freebase.com/ns/m.03dztsj +
, http://www.wikidata.org/entity/Q5192265 +
, https://global.dbpedia.org/id/4ia2f +
|
| rdf:type |
http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/ontology/Company +
, http://schema.org/Organization +
, http://www.w3.org/2003/01/geo/wgs84_pos#SpatialThing +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/WikicatCompaniesInTheNASDAQBiotechnologyIndex +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnNASDAQ +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfTheUnitedStates +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1992 +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/ontology/Agent +
|
| rdfs:comment |
Cubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash ($8.4 billion).
|
| rdfs:label |
Cubist Pharmaceuticals
|
